Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJin‐Kuk Kim, Timothy W. Yu, Chunguang Hu et al.|New England Journal of Medicine|2019Cited by 808
Heterozygous De Novo and Inherited Mutations in the Smooth Muscle Actin (ACTG2) Gene Underlie Megacystis-Microcolon-Intestinal Hypoperistalsis SyndromeMichael F. Wangler, Arthur L. Beaudet, Jeffrey L. Neul et al.|PLoS Genetics|2014Cited by 142
Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal AcidificationElena‐Raluca Nicoli, Braden Boone, Mary Weston et al.|The American Journal of Human Genetics|2019Cited by 97
Pathogenic variants in <scp><i>SQOR</i></scp> encoding sulfide:quinone oxidoreductase are a potentially treatable cause of Leigh diseaseMarisa W. Friederich, Johan L.K. Van Hove, Abdallah F. Elias et al.|Journal of Inherited Metabolic Disease|2020Cited by 62
Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, Silvia Radenkovic et al.|Annals of Neurology|2021Cited by 57